Triplet versus doublet therapy in older patients with metastatic hormone-sensitive prostate cancer: A network meta-analysis. 8-year outcomes of enzalutamide (ENZA) versus a non-steroidal anti-androgen ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, No. 6 (Mar. 19, 2002), pp. 4055-4060 (6 pages) We previously reported that testosterone attenuated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback